Pham Quang X's Form 4 filing
Cadrenal Therapeutics, Inc. (CVKD) · filed May 29, 2026
- Accession no.
- 0001213900-26-062862
- Filed
- May 29, 2026
- Trade date
- May 11-28, 2026
- Filing delay
- 18 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $69.5K. It was filed 18 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pham Quang XCIK 0001405290 | Director, Officer (CEO and Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | SSaleDisposed | −6,476 | $5.76 | −$37,301.76 | 188,448 | Direct | |
| May 12, 2026 | Common Stock | SSaleDisposed | −3,298 | $5.28 | −$17,413.44 | 185,150 | Direct | |
| May 28, 2026 | Common Stock | SSaleDisposed | −2,989 | $4.93 | −$14,735.77 | 182,161 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.